Reply to: Comments on "Secondary cytoreductive surgery (S-CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer: Current evidence and clinical perspectives".

Chang CW, Wang PH, Yang ST, Liu CH, Tjokroprawiro BA

Open source

DOI
10.1016/j.tjog.2026.07.016
Published
2026 Sep
Container
Taiwanese journal of obstetrics & gynecology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tjog.2026.07.016,
  title = {Reply to: Comments on "Secondary cytoreductive surgery (S-CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer: Current evidence and clinical perspectives".},
  author = {Chang CW and Wang PH and Yang ST and Liu CH and Tjokroprawiro BA},
  year = {2026},
  journal = {Taiwanese journal of obstetrics \& gynecology},
  doi = {10.1016/j.tjog.2026.07.016},
  url = {https://doi.org/10.1016/j.tjog.2026.07.016}
}

RIS

TY  - JOUR
TI  - Reply to: Comments on "Secondary cytoreductive surgery (S-CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer: Current evidence and clinical perspectives".
AU  - Chang CW
AU  - Wang PH
AU  - Yang ST
AU  - Liu CH
AU  - Tjokroprawiro BA
PY  - 2026
JO  - Taiwanese journal of obstetrics & gynecology
DO  - 10.1016/j.tjog.2026.07.016
UR  - https://doi.org/10.1016/j.tjog.2026.07.016
ER  - 

APA

CW, C., PH, W., ST, Y., CH, L., & BA, T. (2026). Reply to: Comments on "Secondary cytoreductive surgery (S-CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer: Current evidence and clinical perspectives".. Taiwanese journal of obstetrics & gynecology. https://doi.org/10.1016/j.tjog.2026.07.016

Source records